Apyx Medical (APYX) vs TransMedics Group (TMDX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Apyx Medical (APYX) has outperformed TransMedics Group (TMDX) over the past year, losing 17.8% versus a loss of 33.1%. Over five years, TMDX leads with a +197.6% price change compared with -82.1% for APYX. TransMedics Group is the larger company by market cap ($2.74 billion vs $99.4 million), about 27.6 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | APYX | TMDX |
|---|---|---|
| Share price | $2.36 | $79.00 |
| Market cap | $99.41M | $2.74B |
| 1-day change | -7.45% | -2.55% |
| YTD return | -32.57% | -35.06% |
| 1-year return | -17.77% | -33.08% |
| 5-year return | -82.05% | +197.55% |
| P/E ratio (TTM) | — | 20.47 |
| Forward P/E | — | 35.05 |
| EPS (TTM) | $-0.20 | $3.86 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $605.49M |
| Revenue growth (YoY) | — | +37.13% |
| Net income (latest FY) | — | $190.29M |
| Gross margin | — | 59.92% |
| Operating margin | — | 17.93% |
| Net margin | — | 31.43% |
| 52-week high | $5.08 | $156.00 |
| 52-week low | $2.32 | $60.11 |
| Distance from 52-week high | -53.54% | -49.36% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +175.42% | +26.35% |
| Average volume | 127.72K | 820.41K |
| Shares outstanding | 42.12M | 34.68M |
| Employees | 205 | 898 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- TransMedics Group is about 27.6 times larger than Apyx Medical by market value ($2.74B vs $99.41M).
- APYX has outperformed TMDX by 15.3 percentage points over the past year.
About Apyx Medical
APYX stock →Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM).
Healthcare · Medical Devices · 205 employees
About TransMedics Group
TMDX stock →TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company provides Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body.
Healthcare · Medical Devices · 898 employees
APYX vs TMDX FAQ
Which is bigger, Apyx Medical or TransMedics Group?
TransMedics Group (TMDX) is larger, with a market capitalization of $2.74B compared with $99.41M for Apyx Medical (APYX).
Which stock has performed better over the past year, APYX or TMDX?
APYX returned -17.77% over the past 12 months, compared with -33.08% for TMDX (price return, excluding dividends). Past performance does not predict future results.
Are Apyx Medical and TransMedics Group in the same industry?
Yes. Both are classified in the Medical Devices industry within the Healthcare sector.